Aristo Bio-Tech And Lifescience Limited — Board Meeting, 30-05-2026: Outcome of Board Meeting
30-05-2026 | 03:21 pm
30-05-2026 | 03:21 pm
Aristo Bio-Tech's board approved the financial results for the half-year and year ended March 31, 2026, showing revenue of ₹363.72 Cr and profit of ₹7.18 Cr. They also declared a final dividend of ₹0.60 per share, subject to shareholder approval.
No comments yet. Be the first to comment!
All announcements from Aristo Bio-Tech And Lifescience Limited
